Johnson & Johnson’s Janssen is a pharmaceutical company that produces a variety of biotechnology solutions, including oncology oriented therapies such as Zytiga – a medicine for the treatment of prostate cancer. Marketing efforts for pharmaceuticals are very broad in scope, and require a wide range of services. Velociraster’s role with Zytiga’s marketing was through a cutting edge interactive communication web application.
This communication site had high demands requiring the most cutting edge HTML5 and Javascript practices, highly optimized performance and a cascade robust legacy device support for systems unable to handle the demand of cutting edge features.
Interactive and animation driven marketing sites for mobile an tablets, such as this one for a pharmaceutical drug launch, are a great way to make an impactful impression.
Velociraster has deep animation experience. From 2D keyframed animation, 3D animation systems, and advanced programming driven animation as seen in games, motion effects, and web and apps as seen in the Zytiga project.
Making use of cutting edge technologies can be a double edge sword. It's impressive, but a smaller group of people own the newest technology systems. How to balance cutting edge alongside support for users with older systems isn't trivial and takes extra planning and knowledge of the history of a wide range of technologies and how they have worked throughout time.
Collaboration between an enterprise level marketing department, their relationship with their preferred agency, and understanding our role in helping to delivery quality technology into their broader timelines and goals is one of Velociraster's strengths.
